DEFINITIVE FORM OF NOTICE AND PROXY STATEMENT

Company

BIOCRYST PHARMACEUTICALS INC

Filed

March 27, 2003

Period of Report

May 14, 2003

Accession Number

0001206774-03-000192

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →